(2R,6R)-HNKT148
(S)-Norketamine 42.1, W131
[18F]ASEM T203
[18F]FMeNER-D2 M103
1H-MRS M136, T161
22q11Ds 33.1
2-photon techniques 16.3
5-HT1A receptors W137
5-ht1b M65
5-HT2A receptor T222, W54
7q11.23 M41, M42
7-Tesla M105, T131
ABCD study M200
ABIDE T36
Abstinence M248, T247, T257, W252, W257
Abuse Liability M265, M269
Abuse Potential W157
Acamprosate M234
Accumbens W284
Acetate W263
Acetylcholine 53, 53.1, 53.3, 53.4, M68, M129, W55, W282
Acetylcholine esterase inhibitors, muscarinic receptors, dementiaM236
Acoustic Startle Response T240
Actigraphy T210
Actin Remodeling T245
Activity-Regulated Cytoskeletal Associated Protein (Arc) T230
Acute and Chronic Stress 1.2, 1.3, 20.2, 42.2, 51.1, W30
Acute Stress M86, M125, M165, M167, T32, T232, T239
Adaptive Behavior W162
Addiction 9.3, 30, 40.3, 41.1, 41.2, 50.3, 50.4, 53.2, M281, T52, T255, T271, T273, T275, W44, W238
Addiction Circuitry 23.3, 41.3, 45.3, M231, T233, T270
Add-On Treatment 51
Adenosine 10
Adenosine A2A Receptor W239
Adenosine deaminases acting on RNA M178
Adenosine Triphosphate (ATP) W83
Adjunctive Brexpiprazole T141
Adolescence 39.3, 39.4, 48, 54, M28, M29, M45, M56, M88, M230, M257, M267, M275, T87, T88, W50, W268
Adolescent 2.3, M33, M47, M98, M225, W46, W114, W199
Adolescent Alcohol M227, T234, T264, W268
Adolescent Alcohol Exposure M7
Adolescent Alcohol Use M236, W39
Adolescent Anxiety 2.1, M15
Adolescent Binge Drinking M247
Adolescent Brain and Cognitive Development Study 24, 24.1, 24.3, M34
Adolescent Depression M32, M48, T26, T136, W46, W117, W124, W125
Adolescent Development W281
Adolescent Stress T60, W121
Adolescents M228, T84
Adult 11.4
Adult Anxiety W14
Adult Hippocampal Neurogenesis W153
Adult Stem Cells T254, W212
Adult-Child Interactions T93
Advantages of the Combination of Therapies M183
Adverse Childhood Experiences (ACE) M25, T159
Aerobic Exercise W211
Affective Components of Pain 16.4
Affective Disorders M97, W71, W258
Affective Instability 46.1
Affective Neuroscience T18, T91, W99
Age Effects W277
Aggression M16, M282, T83, T216, W28, W74
Aggressive Behavior W214
Aging M3, M75, T130
Agitation M63, T216
AGN-241751 M124
Agoraphobia M6
Akt W248
Alcohol 35.2, T48, T55, T57, T176, T237, T246, T260, T285, W254, W276
Alcohol Abuse W263
Alcohol and Substance Use Disorders M35, M257, M259, M280, T227, T258, T280, W262
Alcohol Consumption T53, T225, T272
Alcohol Dependence T53, T235, T272, W277, W279, W280
Alcohol Exposure M263
Alcohol Intake W231
Alcohol Seeking M234
Alcohol Sensitivity M251
Alcohol Use Disorder M7, M261, T53, T56, T78, T240, T247, T253, W249, W258, W271
Alcohol Withdrawal W263
Alcoholism M132
Alcohol-Seeking Behavior W239
Aldehyde M251
Aldosterone W271
ALFF M100
Allopregnanolone 8.3, M242, T14
Alpha2 Adrenergic Receptors M222, T216
Alpha7 Nicotinic Acetylcholine Receptor T203
Alpha-7 Nicotinic Acetylcholine Receptor M134, T41, T188, W162
Altitude W259
Alzheimer's Disease 43.3, 53, 53.4, M4, M40, M53, M220, T253, W52
AMPA glutamate receptors 27.3, M119, T271
AMPA Receptor 20.1, M148, T271, W208
Amphetamine M240, W47, W189, W219, W281
Amygdala 17, 17.3, 45.4, 49.4, 53.1, 54, 54.3, M19, M166, M252, T8, T10, T12, T104, T135, T159, T173, T175, T234, T279, T284, W155, W283
Amygdala Ablation W167
Amygdala-Based Networks 35.1, W154
Amyloid M53
Analgesia M270, T157
Anandamide M263
Anger M169
Anhedonia 12.3, 35, 35.1, 35.2, 35.3, 35.4, 41.2, M66, M73, M91, T103, T152, W97, W252
Animal Model M270, M273, W194
Animal Research W266
ANK3 T102, T109
Anorexia Nervosa 15, 15.1, 15.2, M59, T98, T99, T101, W60, W63
Anterior Cingulate Cortex (ACC) M80, M87, T56, W62, W269
Anterior Prefrontal Cortex T195
Antibody M52, M186
Antidepressant 34.2, 42, 42.1, T31, T69, T125, W89, W96, W137, W153
Anti-Depressant T102
Antidepressant Effect M148
Antidepressant Response M2, T29, W132, W138
Antidepressants 20, M72, M76, T123
Antinociception M235
Antipsychotic M184, T44, T184, W199
Antipsychotic Medication M196
Antipsychotic Response T186
Antipsychotic Treatment M210, W201, W207
Antipsychotic Unduced Weight Gain W151
Antipsychotic-Associated Obesity M38
Antipsychotic-Naïve First-Episode Schizophrenia 25, 25.2, M203, W203
Antipsychotic-Naive Schizophrenia 25, 25.4, 29.2
Antipsychotics 25.4, 38, M217, T43, T46, T213, W184, W193, W220, W224
Anti-Psychotics W225
Antisocial 24.2
Anxiety 2, 48, 48.1, M6, M13, M22, M23, M73, M284, T8, T10, T72, T73, T78, T80, T81, T105, T155, T223, T234, W94
Anxiety Circuitry 45.3, M10, M12
Anxiety Disorders 53.2, T5, T12, W15
Anxiety State 3.4
Apathy W154
Appetite 15.3
Approach/Avoidance T81
Aripiprazole M74
Aripiprazole Lauroxil W186
Aripiprazole Once-Monthly 400 Mg (AOM 400) W184
Arousal W27
Asperger's Spectrum Disorder M170
Assessment 4, W213
Associative Learning 16.1, W79, W255
Astrocyte 26, T106, T281, W83, W152
ATAC-seq T14
A-to-I RNA-editing M178
At-Risk T132
Attachment 37.3
Attention 53, 53.3, M31, M247, T58, T87, T92, W162, W189
Attention-Deficit/Hyperactivity Disorder (ADHD) M36, T16, T18, T58, T86, T90, W29, W47, W61, W65, W156, W157
Atypical Antipsychotics T145, T180
Auditory Deficits In Schizophrenia M175, M181, T205
Auditory Hallucinations T76, W185
Auditory Short-Term Memory M173
Autism Spectrum Disorder (ASD) 11.1, 13, 13.1, 21, 26.1, 26.3, 27.1, 39.2, 43.4, 51.2, M144, M170, M216, T15, T35, T36, T82, T94, T96, T161, W33, W36, W45, W143, W215
Aversion M141
Aversive Conditioning 23.3, 48.1
Avoidance M25, T75, W283
Axons 54.1
Baby Schema T252
Baclofen W276
Balb/c mouse T96
Bariatric Surgery W62
Basal Ganglia M58, T101, W79
Basolateral Amygdala 15.1, M19
Bayesian Modeling M18
BDNF T65, T116, T146, T234, W6, W10, W175, W211
BDNF Delivery 20.2
BDNF Val66Met T116, W78
Bed Nucleus of the Stria Terminalis M284
Behavior T70, T169, T178, W226
Behavioral W108, W119
Behavioral Analysis W230
Behavioral Despair T103
Behavioral Pharmacology T59, W25
Behavioral Phenotyping 7, 7.4, M226
Behavioral Variability 6
Benserazide W225
Benzodiazepines W127
Bereavement 46.2
Beta Arrestin 7.2
Beta Arrestin 2 W153
Betahisitine W220
Biased Mu Agonists 50
Bile Acids M38
Binge Drinking M247, M277, T244, T258
Binge Eating M58
Binge Eating Disorder 15.2, M55, T97, W61, W64
Bioinformatics 11.4, W37, W59
Biomarker 12.1, 20.3, M107, M130, M150, T4, T29, T114, T136, T210, T254, W1, W16, W20, W142
Biomarkers for Risk Assessment M114, W21, W52
Biotypes 25.3, 56.3
Bipolar Depression T95, T119, W130
Bipolar Disorder 11.1, 25, 25.3, 44, 44.1, 44.4, 54.4, M68, M70, M81, M82, M85, M90, M93, M95, M104, M116, M201, T24, T109, T114, T122, T124, T126, T132, T204, W82, W90, W93, W108, W111, W114, W119, W129
Bipolar I Depression W134
Bipolar I Disorder 44.1, W130, W182
Blast M153
Blood-Brain-Barrier M52
Body Mass Index T98
BOLD Imaging 46.3
Borderline Personality Disorder 4.3, 17.3, 46, 46.1, M169, M170, M171
Brain M61, T221, W203, W162
Brain Activation 25.1
Brain Aging W2
Brain Based Markers for Depression M91
Brain Circuit 35.1
Brain Connectivity 29.2, M40
Brain Connectome 56.2
Brain Development 24, 39.1, 48.1, M49, T20, W18, W41
Brain Glucose Metabolism M261
Brain Imaging 18.1, 46.1, T190, W63
Brain Insulin Resistance M197
Brain MRI M109
Brain Networks 25.1
Brain Organoids M241, T15
Brain Stimulation W159
Brain Stress T259
Brain Structural Connectivity M135
Brain Structure 24.1, M15
Brain Transcription 44.4
Brain Volumes M250
Brainstem T48
Brexanolone 8.3
Brief Motivational Intervention T258
Bulimia Nervosa M58
Buprenorphine T259, W85, W136
Buprenorphine/samidorphan M118, T138
Buprenorphine-Naloxone T187, T243, W250
burden of Illness T113
CACNA1C W218
Calcium M146
Calcium Imaging 45.2
Callous-Unemotional 24.2
CaMKII T178, W248
cAMP Signalling 20
Cannabidiol 21, 32, T263, W32
Cannabinoid M265, T278, W146
Cannabis 18, M212, M250, M256, M262, M267, T54, W14, W146
Cannabis Dependence T255
Cannabis Use 28, M33, M142, M182, M228, M253, W14, W262
Cannabis Use Disorder M260, T84, W252
Canonical Correlation Analysis (CCA) M96
Cardiac Autonomic Tone M110
Cardiometabolic Risk W151
Care Giving T252
Cariprazine W130
Catecholamine W7
Caudate T243
Causal Reasoning W165
CB1 receptor 45.4
CBT W10, W17
Cell Adhesion Molecule M274
Central Amygdala T12, T100, T264
Central Nervous System M157, W193
Central Nucleus of the Amygdala M12, M19, T62
Cerebellum W213, W223
Cerebral Blood Flow M42, W156
Cerebrospinal Fluid M219
c-Fos M268
C-Fos-Expressing Ensembles T63, W232
Chemogenetics 9.2, 45, T168, T278, W155, W231
Child Abuse and Neglect T9
Child And Adolescent Psychiatry 33.4, 39.2, W129
Childhood Adversity 47, M39, T275
Childhood Maltreatment T9, T38, W40, W42
Childhood Trauma 54.3, M18, M107, T17, T89, T242, T244, W57
Childhood-Onset Schizophrenia 7.3, M187
Children T19, T86, W44
Children and Adolescents 2.4, 54.3, M40, M199, T95, W31, W34, W38
Chipping W260
ChIP-sequencing W35
Choice Procedure M276, T267
Cholesterol Biosynthesis T246
Choline M206
Cholinergic Anti-Inflammtory Response M112
Cholinergic System M181, 768, W49, W71
Chromatin T14, W247
Chronic Mild Stress T103, T147, T151
Chronic Pain M150, T164, T165, T249, T254, W146, W250
Chronic Pain Treatment 31, W146
Chronic Social Defeat T219, T225
Chronic Stress 53.3, M260, T80, T274, T277, W87, W194
Cingulate 6.2
Cingulo-Opercular Network M20
Circadian W86, W282
Circadian Rhythm T52, T181, W82, W274
Circuit 19, 19.4, T150
Clinical High Risk 29.1, 29.2
Clinical High Risk for Psychosis 25.1, 29, 29.3, M133, M195, M212, T194
Clinical High Risk State for Psychosis 32, M182, M191, W215
Clinical Outcome Prediction W63
Clinical Prediction T26
Clinical Predictors M59, T137
Clinical Psychopharmacology M139
Clinical Stability M184
Clinical Subtypes M202, W11, W166
Clinical Trial 12.1, 28, 32, M32, M246, T71, T119, T211, W31, W91
Clinical Trial Design T4
Clinical Trial Rating Methods W46
Clonidine T189
Clozapine W220
Cluster Analysis W203
CNS Clinical Trials M94, T213, W74, W143
Cocaine 41.1, 45, 53.2, M233, M238, M246, M252, M258, M272, T50, T60, T223, T232, T250, W97, W234
Cocaine Addiction 6.4, M274, T51, T235, T238, T245, T257, W232, W235, W236, W242, W256, W257, W260
Cocaine Reinstatement and Taking T50, W233
Cocaine Seeking 41.3, 45.3, 45.4, M264, T268, W246
Cocaine Self-Administration M278, T50, T52, T277, W230, W247
Cocaine Self-Administration and Reinstatement T59, T226, T284
Cocaine-Related Disorders T256, W264
Cognition 33.2, 56, M49, M83, M133, M180, M190, M195, M215, M236, M275, T41, T47, T58, T67, T166, T185, T188, T193, T212, T238, T255, T281, W90, W147, W150, W211, W235, W281
cognitive appraisal T75
Cognitive Behavior Therapy T92
Cognitive Behavioral Therapy 2.1, M20, M87, M161, T164, T221
Cognitive Control 2.2, M218, T191, W188, W205
Cognitive Control Network 2.1, M34, M79, T25
Cognitive Decline 29.1, M53
Cognitive Enhancement 53.4
Cognitive Flexibility 15.2, W106
Cognitive Functioning 40, 54.2, M82, T17, T71, W89
Cognitive Impairment 29.3, M234, T68, T178
Cognitive Neuroscience M77, W60, W254
Cognitive Reappraisal 46.1, 46.2
Cognitive Remediation T183
Cognitive Subtypes W125
Cognitive Training 29.4
Collaborative Cross and Diversity Outbred Mice T52
Combat PTSD 3, 3.3, M19, M283, W172
Combat Veteran 3.2, 35.2, M160, T174
Common Variant 58.1
Comorbidity T220, T244, W98, W215
Complement M69
Complement Component 4 W197
Complement Factor C4 49, 49.3
Complex Brain Disorders 43.1
Compulsive Behavior 1.4
Compulsive Models Of Drug Use M231, M233, M280
Computation 56
Computational Modeling 3.3, 18, M15, M24, T120, W171
Computational Models Of Decision-Making 3.2, T21
Computational Neuroscience 3, 5
Computational Psychiatry 3, 11.3, 18.1, 39, M37, M48, T98, W171, W190
Computerized Cognitive Training M171, M181, M190, T71
COMT gene T66
Conditioned Cues W282
Conditioned Place Preference T63
Conduct Problems 24.2
Conflict T81
Conflict Monitoring W17
Congenital Malformations T145
Connection T93
Connectivity 54.4
Connectivity-Based Parcellation T153
Connectome 29.2, T257
Connectome-wide association study M43
Connectomics M158
Context 50.4, W239
Context-Induced Reinstatement M225
Contextual Fear M284
Copy Number Variant 33.3, M41, W36
Copy Number Variation M42
Corpus Callosum T172
Cortical Circuit Function 11.1, 25, M216, T39, T181, T182, T190, T204
Cortical Dysplasia T160
Cortical Excitation-Inhibition Balance 36
Cortical GABA W178
Cortical Layers T39
Cortical Plasticity T273
Cortical Thickness 13.3, M35, M94, M200, M261, T242, W18, W172
Cortical Thinning W118
Corticosteroids M159
Corticosterone T34, T96, T103
Corticostriatal Circuit T276
Corticostriatal Networks 1
Corticotropin-Releasing Factor (CRF) 45.1, T231
Cortisol M67, T8, T133, W118, W271
Craving T241, T247, W276, W280
C-Reactive Protein T7, T95
Creativity W126
CRF M282, T13
CRF-R1 T225
CRH T108
CRISPR/dCas9 W175, W247
Cross Species W78
CRP M102, T1, T115, W138
CSF Biomarkers M153
Cue Reactivity M258, T55, T260
Cue Reinstatement W245
Cyclic AMP 20.3
CYP2D6 M74
Cytokine 26.3, M219, T105, T212, W236
cytokines 26.1
Cytomegalovirus T139
D1 Dopamine Receptors 1.3, 1.4, M174, T231, W147, W248, W270
D1/D2 1, T224
dACC 3.4
D-Amino Acid Oxidase W187
DAMPs M99
Dasotraline M55, W29, W64
Data Discovery M138
Data Quality 32
Data Sharing M138
Data Similarity M138
Database W183
d-cycloserine W134
Decision-Making 3.4, M67, M278
Deep Brain Stimulation M264, T37, W160
Deep Indexing M138
Default Mode Network (DMN) M43, M189, T197
Delay Discounting T241
Delirium M50
Delusions T204
Dementia M236, T126, W51, W52
Dementia-Related Psychosis W54
Dendritic Morphogenesis M175
Dendritic Remodeling 1.1
Dendritic Spine 43.2
Dendritic Spines 1.1, 27.1, 40.4, W140
Dentate Gyrus T2, T199, W228
Dependence W255
Depression 1, 1.2, 2, 2.4, 7.1, 8.4, 26, 26.3, 34.4, 35.3, 35.4, 42.2, 52.4, 53, 53.2, M53, M67, M68, M74, M75, M76, M77, M78, M91, M92, M98, M105, M109, M113, M120, M121, M124, M128, M129, M130, M161, M250, T8, T25, T31, T34, T67, T84, T105, T110, T119, T125, T127, T128, T131, T133, T135, T140, T142, T143, T146, T151, T190, T219, W13, W44, W86, W94, W96, W98, W122, W135, W138
Depression Inflammation Cytokine M99, T115, W76, W124
Depression Subtypes M115, T112
Depression-Like Behavior M99, T33, T102, T103
Design M127
Development 54.4, T107, W215
Developmental Neuroscience 39.2
Developmental Psychopathology 39, M46, T17, T132
Developmental Trajectories 35
Developmental Transcriptome 13.3
Deviance Detection M173
Dexmedetomidine M63
Dextromethadone T146
Diabetes W71
Diagnosis 5
Diagnostic Boundaries 25.3, M220
Diagnostic Criteria W22
Diet Induced Obesity M46
Diffusion Tensor Imaging (DTI) 25.4, M4, M93, M192, M195, T9, T177, W1, W62, W107
Diffusion Weighted Imaging 54.2, M135, M210, T153, W75
Digital Assessment 4.1, M82
Dimensional 24.3, 39, 39.3
Dimensions 19.4
Dimensions of Psychosis M220
Disability M155
DISC1 W216
Disease Mechanism 58
Disease Modeling W81
Disorders of Glutamate 12.4, 27.3, W72, W198
Disrupted-in-Schizophrenia 1 T177
Disruptive Mood Dysregulation Disorder 39.2, M93
Dissociation M21, M25, M76
Diversity 22, M202, M224, T167
DNA 11.3, M202
DNA Methylation M116, T7, T179, W16, W101, W249
DNA Sequencing M201
Dopamine 20, 35, 35.3, 35.4, M64, M122, M125, M126, M136, M211, M212, M247, M282, T22, T64, T154, T163, T263, W4, W69, W139, W149, W162, W168, W234, W242, W244, W264, W273, W282, W284
Dopamine 2 Receptor M174
Dopamine Circuitry W70
Dopamine D2 Receptors T243
Dopamine D3 Receptors 50, M235, T276
Dopamine Receptor Type 2-Expressing Striatal Medium Spiny Neuron M264
Dopamine Receptors T37, W79
Dopamine Release T45
Dopamine Transporter T174, T268
Dopaminergic System T28, W90
Dorsal Caudate W201
Dorsal Raphe Serotonin Neurons M66, T80
Dorsal Striatum 16.3, T22, T46
Dorsolateral Prefrontal Cortex W62, W270
Dose Reduction T43
Dose-Response Analyses T35
Doublecortin W153
DREADD 35.1
DREADD Receptor T10
DREADDs 41.3, T48
Drinking T48
Drug addiction 23, 23.4, T230, T282, W269, W274
Drug Cues T250
Drug Discovery 12.2, W278
Drug Discovery - New Approaches 7, 7.2, 31.2, W147
Drug Discovery/Development 55, M274
Drug Discrimination M269
Drug Relapse 16.1, 50.4, M268, T266
Drug Response M142
Drug Side Effects M84, W192
Drug Use W272
D-Serine W187
DSM-5 W22
DTI M95
Dynamic Causal Modeling M188
Dynamic Connectivity M248
Dynorphin T154, T157, T232
Dysbiosis 51.4
Dyslipidemia M217
E/I Imbalance T109
Early Adolescence M17
Early Development 54.1
Early Identification of Risk M37, M44, M227
Early Illness Schizophrenia M191, M193
Early Intervention T71
Early Life Adversity 51.1, M1, M39, M227, T108
Early Life Stress 37.1, 47, M5, M29, M260, T83, T108, T139, T159, W30, W35, W41, W258
Early Phase Drug Development 7.3, 12.1, 55
Early Psychosis 32.1, M194, M200, M218, W207
Eating Disorders M56, M59, W60
Ecological Momentary Assessment 4.2, W272
ECT 19, 19.1, 19.4, M109, W83
EEG 10.2, M155, M156, T85, T178, W13, W48, W141, W226
EEG Biomarkers T51
EEG Synchronization 10
EEG/ERP Electrophysiology T121, T189, W180, W191
Efficacy M55
Effort Based Decision Making Task W65
Effort Choice Task T210
Effort Discounting T201
eIF4E 31.1
Electrical Field Modeling M109, T153
Electroconvulsive Therapy 19.2, 19.3, M162, T28, T134, W120
Electroencephalography M50, M158, T172
Electronic Health Record (Ehr) T208
Electronic Medical Record W73, W173
Electronic Prescribing Warnings M139
Electrophysiology 45.1, M126, M278, T12, T80, T191, W70, W140
ELISA T99
Emergency Medicine W21
Emotion 48.4, T89, T133, T255
Emotion Modulation W158
Emotion Processing 6.4
Emotion Recognition W257
Emotion Regulation 17.3, 46.2, M218, T18, T26
Emotional Processing W103
Emotional Regulation M171, W108, W119
Emotional Response Inhibition M45
Emotional Stress M28
Empathy 9, 9.2, 9.3, W126
Endocannabinoid System 32, M169, M260
Endocannabinoids 31.3, 32.1, M167, T79, T163, T277
Endophenotypes 7, M220
Energy Metabolism M133
ENIGMA Working Group T104
Enkephalin T157
Entropy W176
Environment W260
Environmental Risk Factors W259
Epidemiology M137
Epigenetic Modification M236, M244, W101
Epigenetics 13, M107, M172, M240, T65, T179, T233, T234, T264, W16, W35, W42, W67, W78, W242
Epigenome 11, T162
Epigenomics 52
Epilepsy 27.1, M130, T160, W141, W167
Epiodic Memory T66
EPMS M196
eQTL 44.4, T207
ERK M28, M238
ERP W163
Error Processing M209, W163
Escitalopram M2, M74, M91
Esketamine 42.1, M76, M269, T125, W131
Estradiol M97, M108, M125, T66, T74
Estrogen Receptor T185
Ethanol M131, M277, T62
Ethical Issues M137
Ethics 28, 57, T166
Event-Related Potentials M35, T194
Evidence-Based Approach W183
ExcitabilIty T20
Excitatory Synapses 27.1, 27.2
Executive Function W33
Exercise 15.4
Exosomes M237
Exosomes of Neuronal Origin M197
Expectation Bias T260
Experience M185
Experimental Medicine 12.1
Experimental Therapeutics 12.4, M79, T156
Exploration 3.4
Explore-Exploit Dilemma T21
Exposure T94
Exposure therapy W170
Expression M185
Extended Amygdala M8, T13
Extended-Release Depot M184
Extended-Release Naltrexone M245, T248, W250, W253
Externalizing Disorders M39
Extinction learning T284, W10
Extinction Memory Recall T5, W171
Extracellular Matrix 49, 49.4, T49, W87
Extracellular Vesicles M237
Eye-Tracking W38
F-18 PET Imaging 27.3, M261, W92
FAAH M263
Face Emotion Processing T91
Facial Emotion Processing M191, W24
Factor Analysis W213
Fast Scan Cyclic Voltammetry W273
Fast-Acting Antidepressant W133
Fatty Acid Amide Hydrolase M169
Fatty Acids M49
Fear T12, W6, W18
Fear Conditioning 1.2, 48.2, 48.4, M5, M7, T70, T75, T79, T107, T173, W226
Fear Extinction M7, M167, T5, W8
Fear Generalization M117, T154
Fear Memory M9, W9
Feed Forward Inhibition T270
Feeding T168
Feeding Behavior 15, 15.2
Female 42.2, T169, T225, W28, W97
Fentanyl M232, T267
Fetal Alcohol Syndrome M244
Fetal Brain Development 58.4
Fetal Programming W57
First Episode Psychosis M221, T186, W201, W213, W227
First Episode Schizophrenia M187, T209
First-Episode Psychosis T208
FKBP5 W20, W30, W42
Flanker Task T121
Fluorodeoxyglucose M160, M211
Fluoxetine 1.4, T34, W28, W97
fMRI Biomarkers 12.4, 25.1, M27, M88
fMRI Effective Connectivity T91
fMRI Functional Connectivity 29.3, M257, W104
fMRI Negative Affective Stimuli W57
fMRI Resting State M245
Folate 13
Folic acid 13.1, 13.3
Food Addiction T97, T285, W232
Food Intake 15.4
Forceps Minor W75
Forgetting W9
Fractional Anisotropy W56
Fragile X Syndrome M146, M149, T85, W32
Frontomedial Negativity M193
Frontoparietal W158
Frontostriatal Circuitry M135
Frustration W106
Frustration Tolerance T18
FTO T19
Functional and Structural MRI W167
Functional Capacity 25
Functional Characterization 58
Functional Connectivity 24.1, M100, M142, T42, W202
Functional Genomics 11.3, 11.4
Functional MRI (fMRI) 2.2, 3.2, 12.1, 12.3, 15.4, 18.1, 29.2, 35.3, 40.3, 41.2, 46.1, 46.2, 48, 48.4, 56.3, M16, M34, M44, M45, M56, M57, M79, M91, M96, M142, M161, M165, M188, M189, M207, M209, M249, M252, M256, M258, M260, M262, T16, T36, T37, T54, T55, T59, T66, T69, T72, T129, T135, T175, T190, T201, T221, T240, T248, T250, T252, T255, T258, T260, W5, W17, W19, W34, W38, W61, W62, W63, W99, W103, W106, W108, W109, W119, W176, W205, W218, W256, W266, W269, W275
Functional Neuroimaging M17, T88, T89
G Protein 20.3
G Protein Coupled Receptors 43.3
G Protein Signaling 43.3, M239
G Protein-Coupled Receptors 7.2
G9A T223
GABA 8, 8.2, 8.4, M65, M162, T14, T15, T48, T109, T148, T161, W135
GABA Transmission W279
GABA-A Receptor Positive Allosteric Modulator 8.3, 8.4, W148
GABA-A Receptors M215, T161, T182, W140
GABAB T270
GABA-B receptors W276
GABAergic Interneurons 10.4, M216, M223
GABRA6 M132
Gait speed W4
Galantamine W222
Gambling Disorder T239, T251
Gamma Oscillation 34, 34.4, 36, T163, T217
Gender M131
Gender Differences 42
Gender Identity 24.3
Gene Environment Interaction W41
Gene Expression 44.3, M12, M13, M131, T60, T112, T181, W231
Gene Transcription T179, W175
Genecept Assay M147
Genetic Animal Model W231
Genetic Association 58
Genetic Association Study M187, W197
Genetic Liability T191
Genetic Mouse Model W178
Genetic Risk 43
Genetic Score W37
Genetic Testing 57
Genetic Variability M18
Genetic Variation W216
Genetics M201
Genome-Wide Association Study 44, 44.1, 44.4, M201
Genomic 33, 52.4
Geriatric T69
Geriatric Depression M2, W95
Ghrelin 15.3, W271
Glia 26.1
Global Assessment of Functioning (GAF) T114
Globus Pallidus T42
GLT-1 T279, W245
Glucocorticoid Dysregulation 23.4, W30
Glucocorticoid Receptor 23.4, M70, W249
Glucocorticoids M1, T277
GluN2B 34.2
GluN2C subunit W223
Glutamate 12.2, 20.2, 49, M1, M71, M90, M136, M234, T106, T148, T215, W55, W201, W245
Glutamate GABA 34, 34.2, T127, T205
Glutamate Homeostasis T279, T281
Glutamate Receptor Function 20, 27, 43.4
Glutamatergic Synapses 20.2
Glutamatergic Transmission M121
Glutamine T127
Glutathione (GSH) W200
Goal-Directed Behaviors W239
Goal-Directed Control T261
Gonadal Hormones M9, T23
GoNoGo M252
GPCR 20, 20.3, W278
Graph Theory 19.2, T101
Graph-Based Analysis W176
Gray Matter Volumes T242
GSK3 W246
GSSG W200
Guidance Cues W37, W281
Gut Microbiome 51, 51.1, M38, T105, T221
Gut-Brain Axis 51.4, T221
GWAS 44.1, 58.2, T53, T162, T166, T199, W195
GWAS LOCI M274
habenula M101, M249, W104
habit M67, T22, T237
habit formation T64
habits 6.2, W60
habituation M221
hallucinations T204
Hallucinogen M226, T222
HCN M123
HDAC W145
HDAC inhibitors W231
Health Policy 28
Health-Related Quality Of Life 8.4
Healthy Individuals M62
Healthy Subjects M255
Heart Rate Variability M171, T241
Heat Shock Protein 70 T32
Hemodynamic Response Function M165
Heroin Self-Administration T49, T224, T282
Herpesvirus T139
Heterogeneity W22
Hierarchical Clustering 56.3, M115
High Risk M90
High Throughput Screening 7.4
High-Throughput M51
Hippocampal Shape W118
Hippocampal subfields M159, T131, T253, W39, W120, W182
Hippocampal Volume M92
Hippocampal-Prefrontal M223
Hippocampus 1.2, 16.2, 19.1, 27.2, 45.4, M68, M72, M98, M121, M129, M163, M167, M253, T104, T110, T186, T195, T199, T253, W228
Hippocampus-mPFC Pathway 40.1
hiPSC 44, 58, 58.2, W81
Histone W242
Histone Deacetylase T224
Histone Methylation T223
HIV T159, W251
HIV-Associated Neurocognitive Disorder M230, M241
Hoarding Disorder W11
Homeostasis 10
Homeostatic Plasticity 34.4
HPA Axis 23.4, 37.1, 52.3, M70, T8, W20, W41, W67, W121
Human 19
Human Brain 11
Human Brain Imaging 18, W263
Human Clinical Trial M181, W113
Human Connectome T153
Human Genetics 33, 57, 58.3, 58.4, M201, T53, T167, W15, W173, W218
Human Imaging M75
Human Laboratory Study T79
Human Neuroimaging 24, 29, 33, 35.4, 46, 46.3, M105, M250, T128, T251, W172, W268
Huntington's Disease W74, W145
Hydroxynorketamine 20.1, 42.1, 42.2, M121, M127, T31, W131, W133, W135
Hyperarousal M10
Hypersexual Disorder W67
Hypertension M143
Hypobaric hypoxia W259
Hypocretin T13, T226
Hypothalamus M6, M166, M244, T108, T180
IL-1b M186
Imaging M98, M133, T73
Imaging Genetics T249
Immediately Early Gene M73
Immobility T96
Immune 35, W197
Immune Biomarkers T238, W56
Immune Dysfunction 51.2, T139, W261
immune Markers 26.1
Immune Responses W216
Immune System M157, M275
Immunopharmacotherapy 50.2
Impulse Control 6.3
Impulsiveness 6
Impulsivity 30, 39.4, M62, M64, M65, M254, T56, T261, W69
In Vitro Neuronal Differentiation M146
In Vivo W148
In Vivo Calcium Imaging 15.1, 16.2, 16.4, 40.2, 40.4, M10, M280, T2, T46, T63, T272, W27, W228
In Vivo Imaging 16
In Vivo Microscopy 1.4
Incubation of Cocaine Craving T274
Incubation of Craving for Cocaine And Nicotine M229
Incubation of Drug Craving M272, T51
Individual Differences M231
Induced Pluripotent Stem Cells (iPSCs) 7, 7.3, 44.3, 58.1, 58.3, 58.4, W192, W196, W212
Infancy M5
infant 39.1, 54, W56, W57
Inference and Learning W171
inflammation 35.3, M83, M89, M113, M150, M186, T1, T32, T47, T115, T140, T212, T254, W7, W42, W138
Inflammatory Pain 23.2
Informatics 7.4
Information Processing W189
Infralimbic Cortex T106
Infrared M156
Inhibition 16.2, M216
Inhibitory Control M281
Innate Immunity M99
Innovative Methods 40
Insight W11, W269
Insula 9.2, 15.1, M57, T129, W57
Insular Cortex M21, T100
Insulin M106, T180
Insulin Resistance M1, M107, W193
Interactomes 43.1
Intergenerational Transmission 48, 48.3
Interleaved TMS/fMRI M80, W158
Interleukin 1beta M157
Interleukin-1 W279
Internalizing Disorders M39
Internet W44
Interneurons 40.1
Interoception 6.4, M23, M59, T129, W94
Interoceptive Awareness M59
Interpretation Bias T120
Intestinal Microbiome W124
Intracranial EEG M130
Intracranial Self-Administration T264
Intracranial Self-Stimulation M66
Intranasal Esketamine T116, T118, W89
Intranasal Ketamine W45
Intravenous Drug Self-Administration M235, T233
Intrinsic Connectivity 46.3, T25
Intrinsic Functional Connectivity T36
Ion Channels 7.1, M51
Irritability M93, T18, W38, W74, W106
ISI W180
Journal Function W164
Juvenile M67
Kainate Receptor T70
Kappa Opioid Receptor 23.2, T147, T154, T232, W136, W277
Kappa Opioid Receptor Antagonist 12, 12.3, T187, W168
Kappa Opioid Receptors M140, T268
Ketamine 20.1, 20.2, 34, 34.2, 40.4, 42, 42.1, 42.2, M32, M71, M76, M77, M106, M117, M120, M121, M122, M123, M127, T31, T32, T119, T125, T143, T144, T148, W10, W23, W45, W96, W103, W104, W109, W127, W133, W135, W137, W223
Kinase 43
Kinome W181
Knock-in mouse W278
Kynurenic Acid M180, T215, T218
Kynurenine M180, T215, W225
Kynurenine Pathway T218
Language M189
Large Scale Networks M245, W159
Late-Life Depression M94, M108, M112, W1, W4, W150
Latent Class Analysis W254
Lateral Habenula 34, M28
Lateral Hypothalamus T13, T168
Learning W162
Learning Disability M164
Leptin M46
Lethality Studies 50.2
Leukemia Inhibitory Factor (LIF) W83
Levomilnacipran M94
Light Therapy W86
Likelihood to be Helped or Harmed W186
Lipid Rafts 20.3
Lipids M26
Lisdexamfetamine W64
Lithium T122, T124, W82, W129
Lithium Response T109, W111
Lithium Treatment M104
Local Field Potentials T176, T285
Locomotor Activity M240
Locus Coeruleus M63, M222
Long Access Self-Administration 23.3, W248
Long Non-Coding RNAs T110
Long Term Depression T284
Long Term Potentiation M167, T156, T173
Longitudinal 46.2, W16
Longitudinal Analysis 35.2
longitudinal imaging 39.3, T131, W34, W39
Longitudinal Multimodal Imaging W179
Longitudinal Study T51, T114, W260
Long-Term Safety T184
Long-Term Treatment T124
Long-Term Treatment of MDD T141
LSD T80, T222
Lurasidone T95, W134
M1 and M4 Muscarinic Receptors T45, W51
Macaque Monkey M173
Machine Learning 11.4, 19.2, 39.3, 54.2, M27, T98, T129, T162, T175, W73, W117, W125, W173
Machine Learning Classification M4, M93, M101, T208, W40, W202
Machine Learning Clustering M48
MADRS W85
Magnetic Resonance Imaging T19, T130, W31, W107, W201
Magnetic Resonance Spectroscopy M197
magnetoencephalography T28
Maintanance 38
Major Depression 46, M123, T130, W95, W118
Major Depressive Disorder (MDD) 8.4, 15, 15.3, 19.1, 19.2, M14, M79, M80, M84, M87, M88, M100, M102, M103, M110, T32, T104, T106, T113, T118, T123, T138, T139, T144, T249, W5, W85, W87, W103, W104, W107, W109, W125, W127, W252
Maltreatment M98
MAPK W248
Marijuana M262, T263, W49
Marijuana Policy T263
Mass Spectrometry M205
Maternal T94
Maternal Behavior M5, T259
Maternal Depression 39.1
Maternal Immune Activation 39.1, M30, M60, T176
Matrix Metalloproteinase-9 (MMP-9) T49
MCU W241
MDMA W23, W24
MDPV M233
Mechanism of Action 31.2
MeCP2 W48
Medial Amygdala T60
Medial Forebrain Bundle W160
Medial Geniculate Nucleus T284
Medial Prefrontal Cortex 34.2, 40.2, 40.4, M21, M174, M213, M280, W27, W50, W69, W84, W87, W277, W279
Medial Septum M129, W70
Medication Adherence M208
Medication Assisted Treatment M266
Mediodorsal Nucleus of the Thalamus 49.4
Medium Spiny Neuron 1.1, M119, T49
Melatonin 31.2
Memantine M2, M159
Memory M159, M262, T72, W162
Memory and Learning 16.2, 48.1
Memory Encoding and Retrieval 45, M250
Memory Enhancement M3
Memory Function M1, M197
Memory Reconsolidation 45, 45.4, W9, W246
Menopause M108, T66, W5
Mental Health 24.3
Mental Pain T129
Mentalizing W256
Mesocorticolimbic T33
Mesolimbic Circuitry M58
Mesolimbic Reward Circuitry M228, M277
Meta-Analysis M44, T16, T187, W222
Metabolic Side-Effects W199, W207
Metabolic Syndrome T7, W225
Metabolism W263
Metabolites M120
Metabolomics M26
Metabotropic Glutamate Receptor W262
Metabotropic Glutamate Receptor 2 (mGluR2) M107, T280, W221
Metabotropic Glutamate Receptor 3 (mGluR3) W221
Metabotropic Glutamate Receptor 5 (mglu5) T59
Metalloproteases 49.4
Methamphetamine M245, M255, W24, W270
Methodologies T211
Methylation 13
Methylphenidate W29, W65, W157
Mexican Americans T123
mGlu 2/3 Receptor T31
mGlu2/3 Antagonist W137
mGluR2/3 Agonist 12
mGluR5 M14
mGluR5 Receptors 49.2
Mice T82
Microbiome 51.4
Microbiota 51.2
Microbiota-Gut-Brain Axis 51.1
Microdialysis W47, W69, W131
Microglia 26, 49.3, M69, T44, T108, W1, W92
Microglial Activation T254
MicroRNA M237, T3
Midline Theta Frequency T191
Migraine T158
Mild Traumatic Brain Injury M160
Mind & Body Approaches T220
Mindfulness M23
Miniscope W283
Minocycline T85, W31
miRNA W153
Mismatch Negativity M173, T39, T156, T183
Mitochondria M72, T235
Mixed Manic Symptoms W130
MMN T183, W180
MNK 31.1
Mobile Health T24
Mobile Technology 4, T158
Models 30
Molecular Genetics 7, T167, W82
Molecular Imaging T202
Molecular Mechanisms 12, 19.3, T230, T233
Molecular Neuroscience 52
Monetary Reward T165, T248, W13
Monoamines T65, W132
Monoclonal Antibodies 50.2
Monozygotic W196
Mood 27, T155, W121
Mood and Anxiety Disorders 3, 37.1, 53.1, M126, T158, W139, W217
Mood Disorder 7.1, M83, M89, M114, M224, T111, T120, T134, T152, W91, W92, W100
Mood Disorder Subtypes W125
Morphine W244
Morphology T251
Mortality M50
Motivation M140, M282, T45, T168, T201, W190, W230
Mouse Behavior 53.1
Mouse Genetics T52
Mouse Model 15.2, 40.2, M13, M162, M172, M232, T70, T222, T245, W226
Movement Disorders T170, T171
mPFC M141
MR Imaging W199
MR Spectroscopy M21, M262, T205
MRI 13, 19, 19.4, 39.3, M155, T245, W66, W264
mTOR M106, M272
mTORC1 31.1
Multiplex Families M201
Multi-Triggered Relapse M229
Mu-Opioid Receptor T34, T125, T157, T202
Muscarinic Acetylcholine Receptor 53.4, M183
Muscarinic Receptors M236
Mutation 33.2
Myelin 54
Myelin Imaging M41
Myoinositol M206, W100
N-Acetylaspartate W198
N-Acetylcysteine 2.3, M180
NADPH oxidase 10.4
Naltrexone T187, W253
Natural Language Processing (NLP) T208
Negative M185
Negative Affect 23.2, T79
Negative Allosteric Modulator T59
Negative QT Study M118
Negative Reinforcement 23.3
Negative Symptoms M202, T210, W190
Neonatal W58
Nest-Building T147
Network Based Statistic (NBS) T77
Network-Analysis T29, T235
Neural Circuitry 15, 29, 54.4
Neural Circuits M65
Neural Heterogeneity 41
Neural Oscillations W227
Neural Plasticity 16
Neural Progenitor Cells M146, W36
Neuregulin-1 W178
Neurexins W174
Neuroanatomy M81
Neurobehavioral Disorders 33
Neurochemistry M206, T265
Neurocircuits 41, T111
Neurocognition M253, W165
Neurocognitive Functioning M155, M187
Neurodevelopment 26.1, 26.3, 54.2, M143, T91, T182, T245, W55, W179
Neurodevelopmental Disorders 7.3, 14, M30, M37, M42, M144, M241, T97, W59, W212
Neuroeconomics 18.1
Neuroendocrine responses M165
Neuroendocrinology M108
Neuroepigenetics T50
Neurogenesis Enhancers 58.4, W9
Neurogenetics 33.3, 33.4
Neuroimaging 2, 33.4, 39, 56, T78, W154
Neuroimaging Biomarkers 2.4, 12.2, M94, W117, W207
Neuroimmune W236
Neuroimmune Activation M244
Neuroimmune Mechanisms W179, W279
Neuroimmunology M60, T130, W59, W230
Neuroinflammation 26, 51, M51, M283, T44, W152, W267
Neurological Soft Signs M196
Neuromelanin W264
Neuromodulation 16.3, 17, 40.3, M47, M156
Neuronal Activity W6
Neuronal Ensemble 37.3
Neuronal Nitric Oxide Synthase 10.2, T173, W71
Neuropathic Pain 16.4, 31, 31.1, 31.2, 31.3
Neuropathology M153
Neuropeptides M205
Neuropharmocology T172
Neurophysiology 36, W21
Neuroplasticity 29.4, M72, W141, W262
Neuroprotection M2
Neuropsychiatric Disorders 14, 16, 43, T162
Neuropsychiatric Symptoms (NPS) T159
Neuropsychology T38, W95
Neuropsychopharmacology W164
Neuroscience Training 22
Neurosteroid 8, 8.2, 8.3, M242
Neurostimulation M109, W33
Neurosurgery T160
Neuroticism T127
Neurotransmitter Co-Release W55
Neurovascular Coupling M165
New Technology 52
Next Generation Sequencing M132
N-Glycosylation M179
NGR/p75 M175
Nicotine M230, M237, T58, W55, W245, W255
Nicotine Addiction M249, M275, T283, W163, W243
Nicotine Dependence T242
Nicotinic Acetylcholine Receptors 53.1, T87, W162
Nicotinic Receptors W282
Nitrites M217
NKCC1 W178
NMDA Antagonists T146, W211
NMDA glutamate receptors 27.1, 49.2, W243, W246
NMDA Receptor 20.1, 34, M124, T156, T217, W84, W134, W142
NMDA-R antagonists W223
nNOS 10
NODDI T177
Non Human Primate 37, M235, T37, W179, W188
Non Pharmacological Interventions T24
Non-Coding DNA 11
Noncoding RNA 11.1
Nonhuman Primate Models 37.2, 54.1, M29
Non-Suicidal Self-Injurious Behavior 2.3
NOP Receptor Antagonist W25
Noradrenaline T4, T10
Norepinephrine M122
Norepinephrine Transporter Gene (SLC6A2) T90
Nosology W22
Novel Antidepressant T147
Novel Targets 31
Novel Therapeutics 50.3, M23, W142
Novelty Response M221
NR2B Receptor W135
NRXN1 58.1
Nuclear Factor Kappa B W245
Nucleus Accumbens 1.1, 1.2, 1.3, 12.3, 35.1, 45.3, M119, T50, T163, T219, T230, T248, T270, T282, T285, W87, W243, W273
Nucleus Accumbens Shell 45.1, M264, T280
Number Needed to Harm W186
Number Needed to Treat W186
Nutrition M49
Obesity 15, 15.4, M95, M217, T19, T100, W62, W122
Observational Learning 48.2
Obsession W166
Obsessive-Compulsive Disorder (OCD) 1.4, 2.2, 6.2, 40.2, M20, M25, M147, T65, T77, T92, T97, W10, W17, W31, W66, W160, W165, W166
Obsessive-Compulsive Disorder (OCD) Phenotypes M147
Obsessive-Compulsive Symptoms 1
Olanzapine M182, W220, W224
Older Adults T67
Olfaction W150
Olfactory T2
Omega-3 Fatty Acids M71, T107
Open Chromatin 58.2
Open Neuroscience M138
Opiate Addiction 6.4, M268, M274, T243, W275
Opiate Epidemic M268
Opiates 9.2, M270
Opioid 18, W283
Opioid Abuse M266, M271, M276, T267, W152
Opioid Addiction 18.1, M232, M235, M266, T241, T248, T257, W259, W260, W266
Opioid Agonist Treatment 50.4, M266, T252
Opioid Antagonist Treatment M276, T269, W224
Opioid Dependence 9, 23, 23.3, 23.4, M270, M271, M273, W250
Opioid Epidemic- Novel Approaches 9, 31
Opioid Overdose T269, W253, W259
Opioid Receptors T269
Opioid Tolerance M271
Opioid Treatment T259
Opioid Use Disorder T262
Opioid Withdrawal W241
Opioids 16.4, 23.2, 50, 50.3, M265, T157
Optogenetics 45, 45.1, M264, T22, T39, T62, T168, W155, W239, W284
Orbitofrontal Cortex (OFC) M8, W57, W155, W165
Orexin T13, W15
Orexin Receptor Antagonist M268, T226
Orexin System T40, T283
Orphan Receptors 21
Oscillatory Activity 36, T151
Outcome T262
Ovarian Hormones T169
Overeating T97
Oxidative Phosphorylation M177
Oxidative Stress W72
Oxytocin 37.2, M207, T35, W19
Oxytocin Receptor W233
P2X7 26, 26.3, W91, W92, W113
P300 T194, T205
Pain 23, W148, W168, W283
Pain Analgesia 18
Pair Bond M163
Panic M6, W15
Panic Attacks M13
Parabrachial T62
Paranoia M194
Paraventricular Nucleus of the Thalamus 45.1, 45.2, 45.3, T40
Parent - Child Dyads 48.2, 48.4
Parvalbumin Interneurons 10.4, M223, T20
Parvalbumin Neurons 40.1, M177, W50
Pathophysiology T65
Pathway Analysis W75, W261
Pattern Recognition Receptors M99
Pavlovian Conditioning M280, T100
pCREB W241
Pediatric 2, T92
Pediatric PTSD 48.3, W40
Peptidomics M205
Perceived Stress W272
Perception W63
Perceptual Learning T193
Perfusion M42, M45
Periaqueductal Grey (PAG) W241
Perimenopausal Depression M108
Perinatal Stress W58, W59
Peripheral Biomarker M89, T140, T209
Persecutory Ideation M194
Personal and Social Performance (PSP) T114, W184
Personality 39.4, M114
Personalized Medicine M147, T124
Pesticides M144
PET Imaging Study T256
PET Probe W208
PFC M275, W75
Pharmacodynamics W219
Pharmacoegenetics M74
Pharmacoepidemiology T94
Pharmacogenetic Response M84
Pharmacogenetics T123, W82
Pharmacogenomic-Guided Treatment Recommendations M84
Pharmacogenomics M147, W151
Pharmacokinetic and Pharmacodynamic W187
Pharmacokinetics T86, W51, W221
Pharmacology M85, M215
Pharmacotherapy M270, M273, W23
Phase 1 W51
Phase III Trial 55
Phenotypes 4.1, 4.2, 4.3
Phenotypic Screening W81
Phenotyping 5
Phosphorylation 43, 43.1, 43.2, 43.3, 43.4
Photometry M64
PI3K M272
Placebo Response T142
Plasma Membrane Monoamine Transporter W132
Pluripotent Stem Cells W181
Polydrug Use T265
Polygenic Risk Score M199, M203, T135, T196, W156, W195
Polygenic scores T166, T167, W214
Positive Allosteric Modulator M147, M148
Positive and Negative Syndrome Scale M184
Positive Symptom Factor M186
Positron Emission Tomography (PET) M14, M103, M160, M212, T203, W267, W270
Positron Emission Tomography (PET) Imaging 27, 32.1, M53, M97, M104, M134, M169, M211, M215, T37, T41, T68, T161, W113, W219
Post Traumatic Stress Disorder (PTSD) 3.2, 35.2, 46, 46.3, 48, 54.3, M7, M14, M16, M18, M21, M26, M27, M70, M92, M117, M134, T1, T4, T7, T9, T38, T71, T76, T79, T173, T174, T175, T262, W7, W8, W9, W12, W20, W21, W22, W23, W25, W27, W167, W170
Postmortem 43.2, T206, T271
Postmortem Brain Tissue 44.3, 52.4, M116, M177, T126, T179, W182
Postmortem Human Brain 44, 58.4, T207
Postpartum M126, W121
Postpartum Depression 8, 8.2, 8.3, T259
Potassium ATP channels W193
Potassium Channel W100
PPI T91
Prairie Voles 37, 37.3, M163
Pramipexole W90
Prazosin T4
Precision Medicine T167
Precision Medicine for Depression W4
Preclinical M276
Preclinical Alzheimer's Disease M52, W2
Prediction 2.3, 25.1, 33.2
Prediction Error M193
Predictive Models W73
Predictor Of Treatment Response W120
Predictors of Response M20
Prefrontal Cortex 40, 54, M166, M212, M234, T20, T21, T87, T279, W101, W188, W233
Pregnancy 13.1, M85, M143, M200, T145, T227
Prelimbic T272
Premenstrual Dysphoric Disorder W78
Prenatal M49, T166, T215
Prenatal Exposure 13.3, M60, T218, W49, W56
Prenatal Infection M60
Prenatal Stress M172
Prenatal Stress-Immune Model W57
Prescribing M139
Prescription Opioids 23, 41.2, W229
Prevalence W14
Prevention of Relapse by Voluntary Aerobic Exercise M229
Primary Auditory Cortex M173
Probabilistic Reward Learning T21
Processing Speed W4
Prodrug W157
Proenkephalin T34
Progesterone M97
Pro-Inflammatory Cytokines M112
Proof of Mechanism 12.3
Protein Conformations W174
Protein Dynamics W174
Protein Insolubility M176
Protein:Protein Interactions 49.2, M51
Proteomics 43.2, M13, M72, W238
Proton Magnetic Resonance Spectroscopy M90, T56, T247
PSD 43.1
Psilobybine W23
Psilocybin W99, W126
Psychedelic Medicine T143, T222, W99, W126
PsychENCODE 11, 11.4
Psychiatric Disorders T145
Psychometric Tests W2
Psychomotor Speed M251, T212
Psychophysiology T241, W167, W170
Psychosis 5, 24.1, 33.1, 56, M133, M182, M208, M219
Psychosis Continuum 56.2
Psychosis Risk M199, M209
Psychosocial Stress T96
Psychosocial Treatment T84
Psychosomatic Medicine T220
Psychostimulant T266
Psychotherapy 46, 46.3
Psychotic Disorders M224, T41, T47, W198, W202
Psychotomimetic effects W223
Psychotropic Medications M181, W66
Psyichiatric Disorders W208
Puberty M43
Publication Bias T211
Pupillometry W27
Purine T266
Pyramidal Cell M177
Pyramidal Neuron W54
Quantitative EEG M36
Quantitative Electroencephalography (qEEG) M149, T136
R-(-)-Ketamine W131, W133
Racemic Ketamine and metabolites M119, M128, W133
Racial Ethnic Minority M137
Raclopride T243
Raman Spectroscopy T209
Randomized Double-Blind M55
Rapamycin T82
Rapastinel M124, M269, W84
Rapid Antidepressant 20.1, W84
Rapid Antidepressant Effects 34.4
Rapid Depression Treatment M123
Rapid-Acting Antidepressant M124
Rare Disorders 33
Rare Variation T123
Rat T110
Rat models 9.2, M230
Rater Reliability W88
Rating Scales W46, W143
Readmission risk T208
Real-Time fMRI Neurofeedback 17, 17.3, M87
Reappraisal T73
Recent Onset Psychosis T203
Receptor Heteromerization T231
Receptor Internalization Trafficking, M239
Receptor Occupancy W113
Reciprocity T93
Recovery Definition W213
Recruitment 22
Regulatory 58.2
Regulatory Policy 21
Reinforcement M282, T264
Reinforcement learning T21, T89, T142, W190
Reinforcement-based decision-making W238
Reinstatement 50.4, T223, T224
Relapse T113, W232
Relapse and Treatment Outcome 18.1
Relapse Biomarkers M208, M252, T55
Remifentanil M276
Remote Memory T3
Repastinel 34.2
Repetitive Transcranial Magnetic Stimulation (rTMS) M47, T273
Replication M127
Reproducibility M127
Research Domain Criteria (RDoC) M155, T23, W94
Resilience M25, M161, T150
Respiration T10
Response Inhibition T16, T261, W34
Resting State T186
Resting State fMRI 2.3, 39.1, M79, M80, M97, M100, M136, M230, M248, M257, T25, T77, T90
Resting State Functional Connectivity M27, M36, M43, M101, M102, M136, M158, M164, M208, M231, M255, T35, T54, T56, T67, T74, T76, T92, T98, T152, T186, T197, T204, W12, W58, W109
Resting State Networks M96
RET biosensors W278
Retention 22
Retina W86
Rett Syndrome W48
Reversal Learning M30, W70
Reward 19.4, 41, M66, T54, T62, T265, W61, W155, W190
Reward and Aversion 16.4, 41.3, W168
Reward Circuitry 15.3, 45.2, M88, T176
Reward Functioning T152
Reward Learning T22, T64
Reward Neural Circuitry 35
Reward Processing M31, T190
Reward Self-Administration W232
Reward Sensitivity M65
Reward-Based Decision-Making M64, M194
Rhesus M8
Ribosome Profiling M205
Right Temporo-Parietal Junction M207
Risk 24.4, T94
Risk and Resilience M88, T17, T227
Risk Factors W214
Risk for Social Anxiety Disorder M17
Risk-Taking M81
Risky Decision-Making 41.3, M33, M245, M254, T239, T276
RMTg M141, W237
RNA Sequencing 44, 44.4, M143, T33, T206, T235, W78, W244
RNA Splicing 44.3
RNAscope Fluorescence in Situ Hybridization T182, T207
RNA-seq M30, M61
Rodents 19
Safety M55, M118, W51, W221
Salience Network M259, T89
Samidorphan W85, W136
Satiation W61
Schizophrenia 11.3, 12.2, 12.4, 25, 25.3, 25.4, 26.1, 29.1, 29.4, 32, 38, 43.2, 43.4, 49, 49.4, 58.1, 58.3, M172, M176, M177, M178, M180, M184, M185, M188, M196, M197, M201, M202, M206, M207, M210, M215, M216, M217, T40, T42, T43, T44, T46, T179, T183, T188, T191, T193, T196, T201, T202, T210, T212, T213, W36, W182, W184, W186, W193, W195, W197, W200, W214, W221, W222, W224
Schizophrenia Genetics M179, W194
Schizophrenia Negative Symptoms T45
Schizophrenia Novel Treatment M183, M186, M190, T184, T185, T187, T189, T213, W183, W187, W219
Schizophrenia Spectrum Disorders 56.3
Schizophrenia Subtypes 25, W217
Schizophrenia-like Behavior 49.3, M222, T218
Schizotypal Personality Disorder W195
Schizotypy W195
Schnurri-2 Knockout Mice W180
Screening 7.1
Seasonal Affective Disorder M68
Seizures 21, T160
Self-Administration M225, M269, T278, T267, W229, W234, W237, W274
Self-Efficacy M81
Self-Injurious Behavior M162
Self-Referential W269
Semantic W166
Senescence Associated Secretory Phenotype W1
Sensitive Period W149
Sensitization M240
Sequencing 11.3, M202
Sequential Parallel Clinical Design T138
Serious Mental Illness T196
Serotonergic System T28
Serotonin M6, M111, M157, M284, T106, W139, W149
Serotonin 1A Receptor M284, T155, W28
Serotonin 5-HT2A Receptor M226
Serotonin 5-HT2C Receptor 50, M239, W275
Serotonin And Norepinephrine Reuptake Inhibitor M103, W69
Serve And Return T93
Sex M89
Sex Differences 53.3, M9, M43, M110, M127, M128, M134, W138, W258, M281, T33, T60, T83, T111, T147, T151, T165, T218, T267, T274, W5, W30, W57, W59, W76, W132, W164, W229, W234, W272, W274, W280, W281
Sex Hormones M128, T23, W122, W280
Sex Steroids T112
Shared Emotional Affect 9
Short-Term Clinical Studies M183
Signal Transduction W181
Signaling Networks 43.1, M51
Sign-Tracking 6.3
Simulated Driving M256
Simultaneous PET-MR W145
Single-cell RNA sequencing 52.3, W8, W182, W261
Single-Cell Sequencing 52, 52.4
Single-Nucleus T206
Skin Conductance Responses 48.2, T5, W21
SLC39A8 M179
Sleep 1, 10.2, M36, M78, T219, W86, W142
Sleep Deprivation M36
Sleep Disturbance 1.3, M31, T158
Sleep-Dependent Learning T193
Slow Wave Activity 10.2
Slow Wave Sleep 10.2, 10.4
Slow-Wave Sleep 10
Smartphone-Based App M82
Smoking T237
Smoking Cessation W251
SNP M239, T197
Social M131
Social Anxiety T88, W13, W32
Social Anxiety Disorder M254
Social Behavior 37, 37.2, 48.4, M30, M163, T57, T83, W24, W50, W228
Social Cognition 56.2, 56.3, M188, M191, T24, W121, W256, W257
Social Defeat Stress 1.1, M28, M66, M73, T102, T225
Social Function 56
Social Functioning W32
Social Processing 33.1
Social Reward M17, M254, W13
Social Status W28
Social Stimuli M254
Social Stress Buffering M5
Social Withdrawal M220
Soluble Epoxide Hydrolase T99
Somatomotor W158
Somatosensory Network T101
Somatosensory Processing W24
Somatostatin 40.1, M223
Spatial Memory M45
Spinogenesis 16.3
State Dependence W158
Stem Cells W36
STG M206
Stimulant Dependence M231
Stopping T16
Stress 34.2, 52.3, M69, M129, T150, W76
Stress Models T14, T275
Stress Reactivity 15.3, M39, M244
Stress Resilience T3
Stress Response Circuitry M110
Stress-Immune Dysregulation W57
Stress-Induce Psychopathologies 52.3
Striatal Pathways M208
Striatum 7.2, T64, T280
Structural MRI 19.2, 25.2, 25.3, M19, T38, T242, W107, W114, W203
Structural Neuroimaging 24.4, 39.2, W111
Structure Of Psychopathology 39.4
Subcallosal Cingulate M80
Subcortical Shape Analysis M58, T104
Subgenual Cingulate Cortex T133, T206
Subjective Cognitive Decline W2
Subjective Cognitive Impairment W2
Subjective Response W276
Substance Abuse M241, M283
Substance Abuse Disorders 53, T249, W139
Substance Use Disorder M266
Subtypes 25.2
Suicidal Behavior W173, W214
Suicidal Ideation M14, T118
Suicidal Ideation And Behavior Assessment Tool W88
Suicidality M48, T140, W103, W134
Suicide 4, 4.1, 4.2, M61, M70, M86, M89, M113, T23, T25, T122, W93
Suicide Assessment 4.3, W93
Suicide Prediction M101, W73
Support Vector Machine (SVM) T57, W107
susceptibility T150
Sustained Antidepressant T148
Sustained Remission T141
Sympathetic Nervous System W124
Symptomatology M100
Symptoms M185, W215
Synapse 26.1, 34.2, 43, 49, 49.3
Synaptic Aberrations 12.4, 43.4, 49.4
Synaptic Density M75, T256
Synaptic Organizers W174
Synaptic Plasicity W147
Synaptic Plasticity 19.3, 27, 27.2, 27.3, 31.3, 41.2, 43.4, T49, T270, W243
Synaptic Protein Interaction Networks W174
Synchrony T150
Synthetic Opioids 50.2
Synthetic Psychoactive Cathinones M233
TAK-653 M148
Tardive Dyskinesia T170, T171
Target Engagement 12.2, W185, W189
Targeted 38
Targeted Cognitive Training T183
Task-Based Functional Connectivity 54.3, M259, T26, T195, W275
Taste M57, W63
TDCS W185
TDP-43 T126
Technology 58.3
Telemedicine T164
Teletherapy T164
Telomere M86
Temperament M114, M227, W217
Temperature Regulation M140
Testosterone W67
tGSH W200
Thalamus T260, T283
THC M267, T54, T215, T263, W237, W261
Theory of Mind M207
Theta 36, M193, W191
Theta Burst Transcranial Magnetic Stimulation W12
THIK1 M277
Thorough QT study M118
Threat 48
Threat Conditioning 3.3, 48.3
Threat Faces M24, M191
Threat of Shock T240
Thyroid Hormone M22
Tic Disorders M47
Timing T163
Titi Monkey 37
TMS M3, M149, T55, T261, W141
TMS EEG T153
TMS Targeting M3
TMS-EEG W227
TNF-alpha M219
Tobacco W267
Tobacco Smoking M248, W251
Tolerance M226
Toll-Like receptors (TLRs) M60, M242
Top-Down Control M24
Touchscreen T121
Tourette syndrome M47
Toxins M144
Toxoplasma W216
Tract Tracing W75
Transcranial Direct Current Stimulation M213
Transcranial Magnetic Stimulation T137, T172
Transcription Factor M73
Transcription Imputation M18
Transcriptional Profiling W244
Transcriptome 11.1, T135, T162
Transcriptomics 7.2, 33.4, 52, 52.4, M238
transcutaneous auricular vagus nerve stimulation (taVNS) M110
Transdiagnostic T137
Transdifferentiation W212
Transgenic Mice 1.3
Transient receptor potential (TRP) A1 M140
Translational Approaches To Drug Development 12
Translational Biomarker Development M52
Translational Neuroscience 6.3, 40, T68
Translational Research 6, 14, 27, W7
Translocator Protein T44
Trauma W16
Trauma Exposure T196, W19
Traumatic Brain Injury (TBI) M92, M113, M153, M283, T254, W176
Traumatic Memories M22
Treatment 29, M78, W33
Treatment Access T134
Treatment Markers 2.4
Treatment Outcome Prediction W17
treatment resistant T144
treatment resistant cohort M115
Treatment Resistant Depression M84, M106, M148, T115, T116, T128, W89, W98
treatment response T84
Treatment-Naive T247
Treatment-Response 2, M203, W205
Tretment Response M182
Trichotillomania W72
TSPO T246
TSPO and [11C]PBR-28 PET T254
Twins W196
Two Photon Microscopy 40.4, 45.2
Two-Photon 16.1, T39
Ubiquitination M176
Uncertainty 3.2, 3.4
Unconditioned Responses T5
Vaccine Immunotherapy 50
Vagus M112
Valbenazine T170, T171
Validation W88
Valproic Acid T82
Vapor M232
Varenicline M246
Vascular W114
Vasopressin 1A Receptor Antagonist W74
Ventral Hippocampus T155, W70
Ventral Pallidum 41.1
Ventral Striatum M209
Ventral Tegmental Area (VTA) M62, M64, M105, M123, M126, M277, T277, W35, W244
Ventromedial Prefrontal Cortex T272
Verbal Episodic Memory M192
Veterans M92, W172
Vicarious Learning 48.3
Virtual Reality 16, 16.1, 16.2
Visceral Obesity W199
Visual W176
Visual Attention T90
Visual Cortex T87
Visual Information Processing W11
Visual Memory T90
Visual Perception M24
Visuospatial Ability M164
Visuospatial Working Memory T182, T190
Voltage-Gated Calcium Channel M146, T217, W218
Voltammetry W284
Volume T199
Voxel-Based Morphometry (VBM) W40, W235, W257
VTA T279
Vulnerability T110, W234, W238
Vulnerability Traits W262
Weight Gain W220
Wellbeing W126
White Matter M95
White Matter Integrity W118
White Matter Neurons 10.4
Whole Exome Sequencing M132
Whole Genome Sequencing W192
Whole-Brain Rodent Imaging T68
Whole-Genome 11.3, M202
Williams Syndrome 33.3, M41
Withdrawal M270, M273, T43, T226
Within Person Variance 32
Wnt Signaling W83
Women's Mental Health T23, T74, T145
Word Embedding Clustering W166
Workforce 22
Working Memory 40.1, M3, M171, M192, M223, T26, T195, T261, W5, W159, W191, W218, W277
World Trade Center Responders W20
Worry T73
Young Adults W34
Youth 24.4, 48.3, 54.4, W106
β-arrestin 43.3
Rights and permissions
About this article
Cite this article
ACNP 57th Annual Meeting: Keyword Index. Neuropsychopharmacol. 43 (Suppl 1), 563–576 (2018). https://doi.org/10.1038/s41386-018-0270-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41386-018-0270-y